19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Salient type 1 interleukin 1 receptor expression in peripheral non-immune cells

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Interleukin 1 is a pleiotropic cytokine that mediates diverse functions through its receptor, type I interleukin 1 receptor (IL-1R1). Most previous studies have focused on the expression and function of IL-1R1 in immune cells. Here we performed a comprehensive mapping of IL-1R1 distribution in multiple peripheral tissues using our IL-1R1 reporter (IL-1R1 GR/GR) mice. This method yielded the highest sensitivity of in situ detection of IL-1R1 mRNA and protein. Besides validating previously reported IL-1R1 expression in the endocrine tissues including pituitary and pancreas, our results refuted previously reported exclusive IL-1R1 expression in neurons of the spinal cord dorsal horn and dorsal root ganglia (DRG). Instead, IL-1R1 expression was detected in endothelial cells within DRG, spinal cord, pancreas, colon, muscles and many immune organs. In addition, gp38 + fibroblastic reticular cells (FRCs), rather than tissue macrophages or other immune cells, were found to express high levels of IL-1R1 in colon and many immune organs. A functional test of spleen FRCs showed that they responded rapidly to systemic IL-1β stimulation in vivo. Taken together, this study provides a rigorous re-examination of IL-1R1 expression in peripheral tissues and reveals tissue FRCs as a previously unappreciated novel high IL-1R1-expressing cell type in peripheral IL-1 signaling.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: not found

          The IL-1 family: regulators of immunity.

          Over recent years it has become increasingly clear that innate immune responses can shape the adaptive immune response. Among the most potent molecules of the innate immune system are the interleukin-1 (IL-1) family members. These evolutionarily ancient cytokines are made by and act on innate immune cells to influence their survival and function. In addition, they act directly on lymphocytes to reinforce certain adaptive immune responses. This Review provides an overview of both the long-established and more recently characterized members of the IL-1 family. In addition to their effects on immune cells, their involvement in human disease and disease models is discussed.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Positive and negative selection of T cells.

            A functional immune system requires the selection of T lymphocytes expressing receptors that are major histocompatibility complex restricted but tolerant to self-antigens. This selection occurs predominantly in the thymus, where lymphocyte precursors first assemble a surface receptor. In this review we summarize the current state of the field regarding the natural ligands and molecular factors required for positive and negative selection and discuss a model for how these disparate outcomes can be signaled via the same receptor. We also discuss emerging data on the selection of regulatory T cells. Such cells require a high-affinity interaction with self-antigens, yet differentiate into regulatory cells instead of being eliminated.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells

              Here, we show that interleukin-1 (IL-1) enhances antigen-driven CD8 T cell responses. When administered to recipients of OT-I T cell receptor transgenic CD8 T cells specific for an ovalbumin (OVA) peptide, IL-1 results in an increase in the numbers of wild-type but not IL1R1−/− OT-I cells, particularly in spleen, liver, and lung, upon immunization with OVA and lipopolysaccharide. IL-1 administration also results in an enhancement in the frequency of antigen-specific cells that are granzyme B+, have cytotoxic activity, and/ or produce interferon γ (IFN-γ). Cells primed in the presence of IL-1 display enhanced expression of granzyme B and increased capacity to produce IFN-γ when rechallenged 2 mo after priming. In three in vivo models, IL-1 enhances the protective value of weak immunogens. Thus, IL-1 has a marked enhancing effect on antigen-specific CD8 T cell expansion, differentiation, migration to the periphery, and memory.
                Bookmark

                Author and article information

                Contributors
                liu.1933@osu.edu
                quan.14@osu.edu
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                15 January 2018
                15 January 2018
                2018
                : 8
                : 723
                Affiliations
                [1 ]ISNI 0000 0004 1799 5032, GRID grid.412793.a, Department of Oncolgy, , Tongji Hospital, Huazhong University of Science and Technology Tongji Medical College, ; Wuhan, Hubei 430030 P. R. China
                [2 ]ISNI 0000 0001 2285 7943, GRID grid.261331.4, Institute for Behavioral Medicine Research, , College of Medicine, The Ohio State University, ; Columbus, OH 43210 USA
                [3 ]ISNI 0000 0001 0807 1581, GRID grid.13291.38, West China School of Basic Medical Sciences and Forensic Medicine, , Sichuan University, ; Chengdu, Sichuan 610041 P. R. China
                [4 ]ISNI 0000 0001 2285 7943, GRID grid.261331.4, School of Health and Rehabilitation Sciences, Division of Medical Laboratory Science, , College of Medicine, Wexner Medical Center, The Ohio State University, ; Columbus, OH 43210 USA
                [5 ]ISNI 0000 0001 2285 7943, GRID grid.261331.4, Department of Microbial Infection and Immunity, , The Ohio State University, ; Columbus, OH 43210 USA
                [6 ]ISNI 0000 0001 2285 7943, GRID grid.261331.4, Department of Neuroscience, , The Ohio State University, ; Columbus, OH 43210 USA
                [7 ]ISNI 0000 0001 2285 7943, GRID grid.261331.4, Center for Brain and Spinal Cord Repair, , The Ohio State University, ; Columbus, OH 43210 USA
                [8 ]ISNI 0000 0001 2285 7943, GRID grid.261331.4, Division of Biosciences, College of Dentistry, , The Ohio State University, ; Columbus, OH 43210 USA
                [9 ]Institute for Behavioral Medicine Research, 460 Medical Center Drive, Columbus, OH 43210 USA
                Author information
                http://orcid.org/0000-0002-3477-5993
                Article
                19248
                10.1038/s41598-018-19248-7
                5768710
                29335509
                e9dd7bbc-517e-4eb9-ad7c-a38f3efb5377
                © The Author(s) 2018

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 12 September 2017
                : 21 December 2017
                Categories
                Article
                Custom metadata
                © The Author(s) 2018

                Uncategorized
                Uncategorized

                Comments

                Comment on this article